EU approves vaccine for children aged 5 to 11

In the European Union, the Comirnaty vaccine from Pfizer and BioNTech has been approved for vaccination of children from five to 11 years old. This was reported on the website of the European Medicines Agency (EMA), responsible for the scientific assessment, supervision and monitoring of the safety of medicines in the EU.

Children will receive two injections of Comirnaty three weeks apart. The dose will be 10 mcg. According to the agency, this dose in young children has the same effect as the dose of 30 micrograms calculated for children 12 years of age and older.

During the studies, the effectiveness of the vaccine in the prevention of covid-19 was established: it was almost 91%. The true success rate can vary between 68 and 98%, the agency said.

The main identified side effects in children are soreness and inflammation at the injection site, fatigue, headache and muscle pain, and chills. The researchers concluded that such consequences outweigh the risks that may arise from infection with CORONAVIRUS.